Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

End-of-day quote Euronext Paris 08/07/2025			5-day change	1st Jan Change
2.400 ^EUR	-.--%		-.--%	-96.67%

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 149K 119K 109K 206K 14.19M 208K 1.41M 549K 7.16M 559K 547K 23.7M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.45M 12.41M 11.33M 21.39M 1.47B 21.6M 146M 56.97M 743M 58.01M 56.75M 2.46B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
11-30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/07/25	Alert wrongly tagged to Safe SA withdrawn	RE
27/12/24	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/09/24	The market burns its idols
05/02/24	Safe: wins its appeal against Neo Medical
28/12/23	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/09/24	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
24/11/23	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Safe Orthopaedics SA Share Price Euronext Paris

Stocks

ALSAF

FR001400RKU0

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics SA

Latest news : Safe Orthopaedics SA

Press Releases: Safe Orthopaedics SA

News in other languages: Safe Orthopaedics SA

Managers and Directors: Safe Orthopaedics SA

Medical Devices & Implants

Financials

Company Profile

08-25	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
06-30	Safe Group améliore nettement ses résultats annuels
05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
03-31	SAFE - Forte dynamique de développement au Venezuela

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	14/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	08/11/2017

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	25/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	25/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS SA	-.--%	-.--%	-	-	149K
STRYKER CORPORATION	+0.85%	-0.24%	-15.42%	+18.87%	126B
SMITH & NEPHEW PLC	-1.29%	-3.83%	-22.78%	+0.85%	12.42B
GLAUKOS CORPORATION	-2.29%	-1.50%	+98.13%	+145.52%	10.95B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.13%	-4.21%	-51.63%	-68.92%	4.1B
DOUBLE MEDICAL TECHNOLOGY INC.	+0.57%	+4.02%	-22.01%	+58.76%	2.77B
INSPIRE MEDICAL SYSTEMS, INC.	-0.65%	+6.43%	-34.28%	-71.67%	1.78B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.12%	-0.84%	-23.32%	-12.99%	1.62B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.47%	-3.59%	-36.96%	-38.68%	1.56B
Average	+0.10%	+0.45%	-13.53%	+3.97%	20.12B
Weighted average by Cap.	+0.48%	-0.47%	-9.80%	+22.66%

	2024	2025
Net sales	5.04M 5.88M 4.72M 4.31M 8.14M 561M 8.22M 55.72M 21.69M 283M 22.09M 21.61M 937M	5.36M 6.26M 5.03M 4.59M 8.66M 597M 8.75M 59.29M 23.08M 301M 23.5M 22.99M 997M
Net income	-1.93B -2.25B -1.81B -1.65B -3.12B -215B -3.15B -21.32B -8.3B -108B -8.45B -8.27B -359B	-4.67M -5.45M -4.38M -4M -7.55M -520M -7.62M -51.66M -20.11M -262M -20.48M -20.03M -869M
Net Debt	11.47M 13.39M 10.75M 9.82M 18.53M 1.28B 18.71M 127M 49.36M 644M 50.26M 49.17M 2.13B	13.11M 15.3M 12.29M 11.22M 21.18M 1.46B 21.39M 145M 56.42M 736M 57.45M 56.2M 2.44B